---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-23-072878"
form_type: "8-K"
ticker: "DRIO"
cik: "0001533998"
company_name: "DarioHealth Corp."
filed_at: "2023-06-20T23:59:59+00:00"
generated_at: "2026-06-13T21:14:14.736678+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# DarioHealth amends warrants and preferred stock certificates to remove anti-dilution price adjustments

## Summary
- Removed provision in May 1, 2023 warrants that adjusted exercise price upon future equity raise below $3.334 per share.
- Amended Series B, B-1, B-2, B-3 preferred stock certificates to eliminate conversion price adjustment in case of subsequent equity sale below $3.00 floor.
- Removed 19.99% blocker from Series B, B-2, B-3 certificates; Series B-2 dividend shares subject to stockholder approval.
- No new securities issued; changes solely to remove adjustment triggers that could dilute existing holders.
- Effective June 14, 2023; filed with Delaware Secretary of State.

## SEC filing metadata
- accession: 0001104659-23-072878
- form_type: 8-K
- ticker: DRIO
- cik: 0001533998
- company_name: DarioHealth Corp.
- filed_at: 2023-06-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 1.01, 3.03, 5.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1533998/000110465923072878/0001104659-23-072878-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1533998/000110465923072878/tm2318898d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-23-072878
- JSON: https://secwatch.observer/filing/0001104659-23-072878.json
- Plain text: https://secwatch.observer/filing/0001104659-23-072878.txt

## Key facts
- Material Agreements
  DarioHealth Corp. amended Warrant Amendment Agreement with Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P. (effective 2023-06-14).
  - Action: amendment
  - Agreement: credit facility
  - Counterparty: Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P.
  - Effective: 2023-06-14
  source text: On June 14, 2023, DarioHealth Corp. (the “Company”) entered into a warrant amendment agreement (the “Warrant Amendment Agreement”) with Avenue Venture Opportunities Fund II, L.P. and Avenue Venture Opportunities Fund, L.P. (collectively, the “Holders”), relating to the warrants issued to the Holders on May 1, 2023 in conjunction with the execution of the Company’s Loan and Security Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1533998/000110465923072878/0001104659-23-072878-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.